The Water Institute of the Gulf announced Wednesday that Justin Ehrenwerth will take the helm as president and CEO starting Jan. 30.
John Caron has been named associate dean of the Krieger School of Arts and Sciences Advanced Academic Programs, effective Jan. 1, 2017.
WAVE Life Sciences Ltd. (NASDAQ: WVE), a genetic medicines company focused on developing targeted therapies for patients impacted by rare diseases, today announced the appointment of Christian Henry, Executive Vice President & Chief Commercial Officer of Illumina, Inc., to its Board of Directors and as the Chair of its Audit Committee.
CeQur® SA, a leader in simple insulin infusion for people with type 2 diabetes, announced the appointment of Robert Farra as chief executive officer, effective today.
Cognition Therapeutics, Inc., a clinical stage neuroscience therapeutics company, announced today that Kenneth I. Moch has been appointed President and Chief Executive Officer of the company. Mr. Moch will also join the company’s Board of Directors.
Robert Arena, an online education executive with experience in course development and program marketing, has been named Senior Director of Online Programs at the Johns Hopkins Center for Talented Youth. At CTY, Arena will oversee all aspects of the center’s renowned online education for academically advanced pre-college students.
Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that Michael Aldridge has joined the company as Senior Vice President, Corporate & Strategic Development.
Epizyme, Inc. (NASDAQ:EPZM), a clinical stage biopharmaceutical company creating novel epigenetic therapies for people with cancer, today announced that it has appointed Pamela Strode to the position of vice president of regulatory affairs and quality assurance.
OCLC is pleased to announce the appointment of Rachel Frick as Executive Director, OCLC Research Library Partnership.
WAVE Life Sciences Ltd. (NASDAQ: WVE), a genetic medicines company focused on developing stereopure nucleic acid therapies for patients impacted by rare diseases, today announced that it has appointed Keith Regnante as the company’s Chief Financial Officer. Mr. Regnante will provide strategic direction and bring substantial management experience to WAVE’s finance and operations functions.
ReShape Medical Inc. today announced the appointment of Michael J. Mangano as President and Chief Executive Officer. Mr. Mangano, whose 20 year career in the medical device field has included numerous commercial leadership roles, joins ReShape Medical as the Company marks one year since the U.S. Food and Drug Administration (FDA) approved its ReShape® Dual Balloon.
(Park Square placed Dr. David Palling)
Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) announced that it has expanded its management team with the addition of Mr. Frank Murphy, who will serve as Cardiome's Vice President of Finance, and Dr. David Palling, who will serve as the company's Vice President of Manufacturing and Supply Chain.
This article contains the list of 100 honorees. If you want to read the article featuring a particular person, please view the Section in which he/she is featured.
Interactions, LLC, a leader in speech and natural language technology and developer of Intelligent Virtual Assistant solutions for enterprise customer care, today appointed Deepak Batheja as Executive Vice President of Technology and CIO, further expanding its roster of experienced leadership personnel. Batheja will primarily focus on expanding Interactions’ rich portfolio of customer care offerings, powered by artificial and human intelligence.
Commuter rail and ferry passengers will be able to pay for tickets with Apple Pay beginning this fall, as part of an expanded mobile ticketing partnership between the Massachusetts Bay Transportation Authority and London-based transportation technology firm Masabi.
Interactions, LLC, a leader in speech and natural language technology solutions, today announced the appointment of industry veteran Jason Bristow to its executive leadership team as Chief Financial Officer.
Wellesley College has appointed Nancy Coleman as Associate Provost and Director, Strategic Growth Initiatives.
Wendi B. Heinzelman, currently dean of graduate studies for Arts, Sciences, and Engineering (AS&E), and professor of electrical and computer engineering, will be the next dean of the Hajim School of Engineering & Applied Sciences. Heinzelman will be the Hajim School’s first female dean and has been appointed to a five-year term beginning July 1, 2016.
Colt Technology Services Ltd., announced today that Kenji Hioki has been named Chief Revenue Officer Asia / Regional Executive effective on 1 May 2016.
Novo Nordisk has appointed Aaron Schwartz as Director, R&D Sourcing. Schwartz joins Novo Nordisk from the MIT Technology Licensing Office where he spent over a decade in various roles of increasing responsibility including: Technology Licensing Officer; Associate Technology Licensing Officer; and Technology Licensing Associate. Prior, Schwartz served as a Business Development and Strategy Consultant at Akceli, Inc. His earlier career was spent as an Analyst at Mercer Management Consulting.
Margaret Levenstein has been appointed the director of the Inter-University Consortium for Political and Social Research at the U-M Institute for Social Research.
Deciphera Pharmaceuticals has appointed David Brooks as Vice President, Clinical Development & Translational Medicine.
Alice Li, Ph.D. ’98, has been named executive director of Cornell’s Center for Technology Licensing (CTL), the university’s patent and technology transfer arm. She had been serving as the group’s interim director since August 2014.
FLX Bio, Inc., a biopharmaceutical company focused on the discovery and development of novel cancer immunotherapies, announced today that it has appointed Rekha Hemrajani as Chief Operating Officer.
DePaul University has selected Dr. Ronald Caltabiano, an internationally recognized composer with more than 25 years of experience in higher education, as the next dean for the School of Music, effective July 1.
Antonio Merlo, the George A. Peterkin Professor and department chair of economics at Rice University, has been appointed dean of Rice’s School of Social Sciences. The appointment is effective July 1.
Poxel SA (Euronext – POXEL - FR0012432516), a biopharmaceutical company focused on the development of innovative drugs to treat type 2 diabetes, today announced that Jonae R. Barnes has joined the Company as Senior Vice President, Investor Relations and Public Relations. Ms. Barnes will be based in the Boston area, a leading area in drug development and innovation.
Sadik Esener, Ph.D., will help launch the OHSU Knight Cancer Institute’s recruitment of 20 to 30 top scientists and their research teams.
Park Square client, Mathai Mammen of Theravance Biopharma, will join Merck this spring to lead a significant portion of the company’s discovery research organization. Mammen founded Theravance in 1996 and has served as Senior Vice President of R&D.
Mary McKernan McKay, the McSilver Professor of Poverty Studies and director of the McSilver Institute for Poverty Policy and Research at New York University’s Silver School of Social Work, has been appointed dean of the Brown School at Washington University in St. Louis, effective July 1, according to Chancellor Mark S. Wrighton.
Following a nationwide search, Karoly Mirnics, M.D., Ph.D., has accepted the position of director of the Munroe-Meyer Institute for Genetics and Rehabilitation.
Nanocomp Technologies, Inc. has appointed Paul Hallee as Chief Financial Officer. Hallee most recently served at Sand 9, Inc. as Chief Financial Officer.
Theravance Biopharma has appointed Richard Graham as Senior Director, Clinical Pharmacology. Graham joins Theravance from Onyx Pharmaceuticals, where he served as Senior Director, Head of Clinical Pharmacology.
Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehydes, today announced that David J. Clark, M.D. has joined the Company as its Chief Medical Officer, effective January 11, 2016.